Shares of Insmed Incorporated (NASDAQ:INSM – Get Free Report) have been given an average recommendation of “Buy” by the ten brokerages that are presently covering the firm, MarketBeat.com reports. Ten research analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts that have issued ratings on the stock in […]
Insmed (NASDAQ:INSM – Get Free Report) issued its earnings results on Thursday. The biopharmaceutical company reported ($1.28) earnings per share for the quarter, missing the consensus estimate of ($1.13) by ($0.15), Briefing.com reports. The firm had revenue of $83.70 million for the quarter, compared to analyst estimates of $82.15 million. During the same quarter in […]
Victory Capital Management Inc. increased its stake in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 6.5% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,486 shares of the biopharmaceutical company’s stock after purchasing an additional 948 shares during the period. Victory Capital […]
Jump Financial LLC grew its position in Insmed Incorporated (NASDAQ:INSM – Free Report) by 68.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 105,949 shares of the biopharmaceutical company’s stock after purchasing an additional 43,234 shares during the […]